Choi SD - Search Results

1

Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus.

Baek WY, Choi YS, Lee SW, Son IO, Jeon KW, Choi SD, Suh CH. Baek WY, et al. Among authors: choi ys, choi sd. Int J Mol Sci. 2021 Nov 25;22(23):12764. doi: 10.3390/ijms222312764. Int J Mol Sci. 2021. PMID: 34884569 Free PMC article.

2

Toll-like receptor signal transduction.

Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S. Krishnan J, et al. Exp Mol Med. 2007 Aug 31;39(4):421-38. doi: 10.1038/emm.2007.47. Exp Mol Med. 2007. PMID: 17934330 Review.

3

Toll-like receptor modulators: a patent review (2006-2010).

Basith S, Manavalan B, Lee G, Kim SG, Choi S. Basith S, et al. Expert Opin Ther Pat. 2011 Jun;21(6):927-44. doi: 10.1517/13543776.2011.569494. Epub 2011 Mar 15. Expert Opin Ther Pat. 2011. PMID: 21406035 Review.

4

Molecular modeling-based evaluation of dual function of IκBζ ankyrin repeat domain in toll-like receptor signaling.

Manavalan B, Govindaraj R, Lee G, Choi S. Manavalan B, et al. J Mol Recognit. 2011 Jul-Aug;24(4):597-607. doi: 10.1002/jmr.1085. Epub 2010 Nov 26. J Mol Recognit. 2011. PMID: 21472811

5

In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2L.

Basith S, Manavalan B, Govindaraj RG, Choi S. Basith S, et al. PLoS One. 2011;6(8):e23989. doi: 10.1371/journal.pone.0023989. Epub 2011 Aug 29. PLoS One. 2011. PMID: 21897866 Free PMC article.

6

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.

Basith S, Manavalan B, Yoo TH, Kim SG, Choi S. Basith S, et al. Arch Pharm Res. 2012 Aug;35(8):1297-316. doi: 10.1007/s12272-012-0802-7. Epub 2012 Sep 1. Arch Pharm Res. 2012. PMID: 22941474 Review.

7

Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.

Gosu V, Basith S, Kwon OP, Choi S. Gosu V, et al. Molecules. 2012 Nov 14;17(11):13503-29. doi: 10.3390/molecules171113503. Molecules. 2012. PMID: 23151919 Free PMC article. Review.

8

Negative regulatory approaches to the attenuation of Toll-like receptor signaling.

Anwar MA, Basith S, Choi S. Anwar MA, et al. Exp Mol Med. 2013 Feb 22;45(2):e11. doi: 10.1038/emm.2013.28. Exp Mol Med. 2013. PMID: 23429360 Free PMC article. Review.

9

Advances in Antiviral Therapies Targeting Toll-like Receptors.

Shah M, Anwar MA, Kim JH, Choi S. Shah M, et al. Expert Opin Investig Drugs. 2016;25(4):437-53. doi: 10.1517/13543784.2016.1154040. Epub 2016 Feb 29. Expert Opin Investig Drugs. 2016. PMID: 26878224 Review.

10

Recent progress in the development of Toll-like receptor (TLR) antagonists.

Patra MC, Choi S. Patra MC, et al. Expert Opin Ther Pat. 2016 Jun;26(6):719-30. doi: 10.1080/13543776.2016.1185415. Epub 2016 May 18. Expert Opin Ther Pat. 2016. PMID: 27136061 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page